Frantz Tumor - Pseudopapillary Cystic Neoplasm of the Pancreas in Children: Report of Two Patients
DOI:
https://doi.org/10.5457/ams.v40i1.204Keywords:
Pseudopapillary cystic neoplasm of the pancreas, Frantz tumor, childrenAbstract
Pseudopapillary cystic neoplasm of the pancreas (Frantz tumor) is rare slow growing tumor with low malignant potential usually affecting young women. PCN have good prognosis in case of radical removal. Tumor was described for the first time by Frantz in 1959. A retrospective clinical analyses was made of two patients with PCN admitted in our hospital in the last 10 years. A 16 year old girl admitted in our hospital with intermittent abdominal pain lasting for 3 years. Abdominal ultrasound and CT-scan showed the presence of the tumor in a head of pancreas. Excision was performed. A 13 year boy came to routine US because frequent urological infection. Abdominal US and after CT are showed the presence of the tumor in a neck of pancreas. Excision was performed. In both of patients metastases were not noticed. The follow up period was 9 years in female patient and 2 years in male patient, Surgical resection of PCN affords an excellent prognosis without other ways of treatments.
Downloads
Published
Issue
Section
License
Copyright transfer
The listed authors warrant that they are the authors and sole owners of the submitted manuscript. The authors also warrant that the work is original; that it has not been previously published in print or electronic format and is not under consideration by another publisher or electronic medium; that it has not been previously transferred, assigned, or otherwise encumbered; and that the authors have full power to grant such rights. With respect to the results of this work, the manuscript of this or substantially similar content will not be submitted to any other journal until the review process in the Acta Medica Salinianana has been officially completed (acceptance or rejection of the manuscript). The paper will not be withdrawn from the review process by the Acta Medica Saliniana Editorial Board until the review process is completed. The authors will comply with the requests of the Acta Medica Saliniana Editors and reviewers to improve the paper for publication. The eventual disagreements will be submitted in a written form; the authors are aware that the disagreement(s) with the Acta Medica Saliniana requests may result in the rejection of the manuscript. The authors hereby grant to the Acta Medica Saliniana the right to edit, revise, abridge, and condense the manuscript. If the manuscript is accepted for publication in the Acta Medica Saliniana, the authors hereby transfer the copyright of the paper to the Acta Medica Saliniana. The authors permit the Acta Medica Saliniana to allow third parties to copy any part of the journal without asking for permission, provided that the reference to the source is given. For papers with more than one author: All other co-authors agree to allow the corresponding author to make decisions regarding prepublication release of the information in the paper to the media, federal agencies, or both.
